Please use this identifier to cite or link to this item:
Title: IP Strategy for Drug Discovery: A Dedicated Research Firm’s Perspective
Authors: Radhakrishnan, Vinita
Keywords: IP strategy;Dedicated research firm;Drug discovery;Licensing;Knowledge management;IP portfolio
Issue Date: Sep-2012
Publisher: NISCAIR-CSIR, India
Abstract: Even though, dedicated research firms rely heavily on the strength of their intellectual property (IP) to strike a favorable licensing deal, they seldom have the bandwidth to maintain a dedicated IP team to strategize the IP in a fashion which would enable them to reap the maximum value from the IP generated. The article discusses how to approach the issue of designing an IP strategy from a dedicated research firm point of view.
Page(s): 478-483
ISSN: 0975-1076 (Online); 0971-7544 (Print)
Appears in Collections:JIPR Vol.17(5) [September 2012]

Files in This Item:
File Description SizeFormat 
JIPR 17(5) 478-483.pdf55.93 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.